Dou­bling down on Sanofi's French roots, Paul Hud­son in­fus­es €50M in­to Jeito Cap­i­tal to boost home­grown biotechs

Paul Hud­son head­ed in­to the Élysée Palace, sum­moned by French Pres­i­dent Em­man­u­al Macron, in deep trou­ble with the coun­try’s gov­ern­ing elites who were of­fend­ed by his sug­ges­tion that the US would get first dibs on Sanofi’s Covid-19 vac­cines.

The CEO emerged, as it would be an­nounced a month lat­er in June, with a plan to in­vest in vac­cine R&D in its home coun­try and a bold de­c­la­ra­tion that “Sanofi’s heart beats in France.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER